NatashaHalasaMD

Pediatric Infectious Disease • Nashville, TN

Associate Professor, Pediatrics, Vanderbilt University School of Medicine

Join to view full profile

Dr. Halasa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Halasa's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Education & Training

Vanderbilt University Medical CenterFellowship, Pediatric Infectious Diseases, 2001 - 2004
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1998 - 2001
The University of Toledo College of MedicineClass of 1998

Certifications & Licensure

TN State Medical License 2001 - 2026
OH State Medical License 1999 - 2022
AL State Medical License 2020 - 2020
American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients Start of enrollment: 2010 Oct 01
Completed
Phase 1
Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients Start of enrollment: 2010 Oct 01
Completed
Phase 1
Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients Start of enrollment: 2011 Sep 01
Completed
Phase 1
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection Start of enrollment: 2013 Apr 01
Completed
A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) Start of enrollment: 2016 Jan 01
Withdrawn
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, Yuwei Zhu, H Keipp Talbot
Vaccine. 2025-01-01
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study.
James W Antoon, Justin Z Amarin, Olla Hamdan, Tess Stopczynski, Laura S Stewart
Clinical Infectious Diseases. 2024-12-17
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, Geoffrey A Weinberg, Mary A Staat
JAMA Pediatrics. 2024-12-09

Journal Articles

Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States
Natasha B Halasa, Kathryn M Edwards, mBio
Immune Responses to Pertussis Antigens in Infants and Toddlers After Immunization with Multicomponent Acellular Pertussis Vaccine
Natasha B. Halasa, Olajumoke O. Fadugba, mBio

Press Mentions

Study Finds Underuse of Antivirals for Hospitalized Children Suffering InfluenzaDecember 17th, 2024
Study Reveals Underuse of Antivirals for Children Hospitalized with InfluenzaDecember 16th, 2024
SARS-CoV-2 Protein Linked to Onset of Multisystem Inflammatory Syndrome in ChildrenAugust 6th, 2024
Join now to see all

Grant Support

New Vaccine Surveillance Network -Patient Protection-AcaNational Center For Immunization And Respiratory Diseases2011
New Vaccine Surveillance NetworkNational Center For Immunization And Respiratory Diseases2011
Neonatal Immunization With Acellular Pertussis VaccinesNational Institute Of Allergy And Infectious Diseases2005–2007